Clinigen new.png
Clinigen launches NaviGATE: an educational programme for rare disease patients and organisations
12 sept. 2023 07h00 HE | Clinigen
12 September 2023 Clinigen launches NaviGATE: an educational programme for rare diseasepatients and organisations             Accessing hard to reach medicines for people who need them most...
Clinigen new.png
Clinigen divests global rights to four cancer support therapies to CNX Therapeutics
10 août 2023 09h46 HE | Clinigen
10 August 2023 Clinigen divests global rights to four cancer support therapies to CNX Therapeutics Clinigen Limited (‘Clinigen’), the global pharmaceutical services company, has completed the...
Clinigen-Group-Plc-logo.jpg
Clinigen initiates a Managed Access Program for relugolix in Europe for the treatment of advanced hormone-sensitive prostate cancer
20 déc. 2022 02h00 HE | Clinigen
20 December 2022 Clinigen initiates a Managed Access Program for relugolix in Europe for the treatment of advanced hormone-sensitive prostate cancer Clinigen Limited (‘Clinigen’), the global...